Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral panretinal laser plus ranibizumab for macular edema due to central retinal vein occlusion
2014-002790-11Phase 4Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Mar 2015
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of ranibizumab in macular edema (2 arms), sponsored by Ludwig Maximilian University of Munich. Primary endpoint: Recurrence of macular edema. Started Mar 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on 2014-002790-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002790-11.